News ArchivesRead News

Your Weekly Parkinson's News Update for the Week of 5.6.19

Monday May 06, 2019
Neurophysiotherapy for Parkinson's
Medical & Life Sciences News
A great deal of clinical research has shown that goal-oriented physical activity/exercise can lead to significant improvement in the ability to walk, and in the dexterity of hands/fingers. With the correct combination of activities, balance may also improve, as well as the speed of movement. Exercise may also have neuroprotective or anti-degenerative effects on the brain.
Neurocrine’s Opicapone Plus Levodopa
Improves Parkinson’s Symptoms
“The analysis of data from these two Phase III trials showed that adding once-daily opicapone to levodopa significantly increased ON time without troublesome dyskinesia, a common concern for patients with Parkinson’s disease,” reported Peter LeWitt, director of the Parkinson’s Disease and Movement Disorders Program at Henry Ford Hospital in Detroit. “We believe this data will translate into real-world benefits for Parkinson’s disease patients on levodopa therapy who experience motor fluctuations, which can be disruptive and impact the patient’s quality of life.”
Developing a Biomarker for Parkinson's
MD Magazine
A biomarker for Parkinson's could mean that patients can begin receiving treatment to intervene with progression. Sarah Hamm-Alvarez, PhD, Professor of Ophthalmology at the USC Roski Eye Institute at the Keck School of Medicine of USC, highlighted the collaborative nature of the project that has included colleagues from the neurology, pharmacy, and preventive medicine departments.
“Part of the passion for the project is driven by the clinical need that I sense from my neurology colleagues and their frustration that they don't have better ways to diagnose patients at early states,” said Hamm-Alvarez.